| BYND 1.17 0.86% | CTNT 0.0388 -29.20% | FCHL 0.2876 27.82% | FFAI 0.4721 64.67% | LOBO 0.725 26.62% | ASBP 0.1949 -25.58% | RPGL 0.6384 41.90% | TZA 5.075 1.60% | XRTX 2.725 21.11% | LOCL 2.7304 45.23% | EDBL 0.7849 -14.68% | BITO 10.4101 -0.48% | SOXS 18.0999 -2.85% | NVTS 15.575 17.99% | BURU 0.2301 15.05% | INTC 66.515 1.24% | PLUG 3.0999 -3.73% | NVDA 200.15 -0.95% | ONDS 10.9199 1.77% | OPEN 5.82 8.79% | POET 10.3 19.91% | SOWG 0.1595 -33.51% | TSLL 13.04 -1.88% | TQQQ 57.91 -0.29% | NOK 10.455 -1.37% | TOVX 0.3243 -20.90% | HIMS 29.805 -3.89% | SOXL 98.64 2.81% | SOUN 7.905 -4.99% | BMNG 1.5101 -2.57% | SLNH 1.5176 8.40% | CLIK 3.46 34.63% | SOFI 19.168 -1.70% | LCID 7.335 8.67% | SQQQ 57.08 0.30% | SPDN 9.175 0.38% | HYG 80.435 -0.18% | SNAP 5.725 -4.58% | SMR 11.995 -6.22% | AAL 11.88 -2.94% | TSLA 389 -0.89% | NVD 5.6984 1.94% | NFLX 93.2855 -1.63% | BULL 7.12 1.57% | PLTR 146.67 0.53% | BIYA 1.1902 36.79% | HTZ 7.04 -9.86% | BTG 4.94 0.00% | TDIC 0.9913 48.07% | BBAI 3.845 0.26%

Solventum Corporation's Stock Performance and Analyst Ratings

Solventum Corporation, listed on the NYSE under the symbol SOLV, is a company that has recently caught the attention of investors and analysts. On January 25, 2026, KeyBanc upgraded Solventum's stock rating to "Overweight" from "Sector Weight," indicating a more optimistic view of the company's future performance. At the time of this upgrade, the stock was priced at $78.91.

Despite the positive outlook from KeyBanc, some institutional investors have adjusted their positions in Solventum. Anchor Capital Advisors LLC reduced its holdings by 2.2%, selling 13,376 shares. This leaves them with 597,911 shares, valued at $43.6 million, representing about 0.34% of Solventum's total shares. Meanwhile, Rakuten Investment Management Inc. acquired a new stake worth approximately $1.1 million.

Other investors have shown increased interest in Solventum. Universal Beteiligungs und Servicegesellschaft mbH increased its stake by 10.6% during the third quarter, now holding 56,069 shares valued at $4.1 million. This indicates a mixed sentiment among institutional investors, with some reducing and others increasing their stakes in the company.

Solventum has received varied recommendations from analysts. Out of fourteen brokerages, the stock has an average "Hold" rating. One analyst suggests "sell," eight recommend "hold," and five advise "buy." The average 12-month target price is $88.64. BTIG Research recently upgraded Solventum to a "buy" with a target price of $100, while Zacks Research downgraded it to a "hold."

Currently, NYSE:SOLV is trading at $78.91, reflecting a 1.68% decrease. The stock has fluctuated between $78.77 and $80.32 today. Over the past year, it reached a high of $88.20 and a low of $60.70. Solventum's market capitalization is approximately $13.69 billion, with a trading volume of 597,641 shares.

Published on: January 26, 2026